Company Filing History:
1 out of 70 
1 out of 1 Years Active: 2013
Title: Inventor Spotlight: Maritza Isidra Barrera Valle
Introduction
Maritza Isidra Barrera Valle is a notable inventor from Ciudad de la Habana, Cuba, recognized for her significant contributions to the field of veterinary science. Her work focuses specifically on developing innovative solutions to combat diseases affecting swine, especially the Classical Swine Fever virus.
Latest Patents
Maritza holds a patent for "Chimeric Vaccine Antigens Against Classical Swine Fever Virus." This invention describes novel chimeric vaccine antigens that aim to prevent the spread of Classical Swine Fever (CSFV) by stimulating both cellular and humoral immune responses in vaccinated pigs. The essence of this invention lies in the ability of these chimeric antigens to be produced in expression systems, ensuring that the tertiary structure of the molecules is correctly folded. The resultant vaccine formulations offer early and robust immune responses, conferring complete protection against CSFV, while also preventing the transmission of the virus from sows to their offspring. This innovation holds great promise for improving animal health through effective vaccination strategies.
Career Highlights
Maritza has made impactful strides in her career, particularly through her work at significant institutions such as the Centro de Ingeniería Genética y Biotecnología and the Centro Nacional de Sanidad Agropecuaria. Her dedication to advancing veterinary medicine through innovative research underscores her commitment to improving animal health and disease prevention.
Collaborations
Throughout her professional journey, Maritza has worked alongside distinguished peers, including Jorge Roberto Toledo Alonso and Oliberto Sánchez Ramos. Their collaborative efforts reflect a shared vision to enhance the field of biotechnological applications in veterinary medicine, thereby contributing to the welfare of livestock.
Conclusion
Maritza Isidra Barrera Valle stands out as a pioneering inventor whose work in developing chimeric vaccine antigens represents a significant advancement in combating Classical Swine Fever. Her contributions not only enhance animal health but also play a crucial role in the agricultural sector's sustainability efforts. As innovations like these continue to emerge, they pave the way for a healthier future for swine and the industries reliant upon them.